CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-99 Cr | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr | ₹31 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-99 Cr |
| Mar2023 | ₹-85 Cr |
| Mar2022 | ₹-100 Cr |
| Mar2021 | ₹31 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-99 Cr | Negative | |
| Mar2023 | ₹-85 Cr | Negative | |
| Mar2022 | ₹-100 Cr | Negative | |
| Mar2021 | ₹31 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,493.9 Cr | -3.3% | -11.2% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -3.3% |
-11.2% |
-42.2% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses